
ELVN Market Capitalization Overview
Market Cap: $1.55B as of Jan 9, 2026
$1.55B
$386.36M (33.40%)past month
As of Jan 9, 2026, ELVN has a market capitalization of $1.55B. Over the past 30 days, its market cap has decreased by -21.71%, while in the last 12 months, it has increased by 68.83%.
Market capitalization represents the total value of Enliven Therapeutics Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
ELVN Market Cap Formula = Stock Price * Shares Outstanding
The market cap of ELVN helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Enliven Therapeutics Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
ELVN Market Cap Formula = Stock Price * Shares Outstanding
The market cap of ELVN helps investors assess the company's size and compare it with competitors for better investment decisions.
ELVN Market Cap & Key Trends
See Enliven Therapeutics Inc’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in ELVN
Order type
Buy in
Order amount
Est. shares
0 shares
ELVN Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| Dec 1, 2025 | $1.18B | -0.56% |
| Nov 3, 2025 | $1.19B | +0.88% |
| Oct 1, 2025 | $1.18B | -5.10% |
| Sep 2, 2025 | $1.24B | +12.00% |
| Aug 1, 2025 | $1.11B | -4.68% |
| Jul 1, 2025 | $1.16B | +23.42% |
| Jun 2, 2025 | $939.19M | -3.45% |
| May 1, 2025 | $972.74M | +5.14% |
| Apr 1, 2025 | $925.21M | -3.49% |
| Mar 3, 2025 | $958.62M | -10.41% |
| Feb 3, 2025 | $1.08B | -8.37% |
| Jan 2, 2025 | $1.17B | -2.17% |
ELVN End of Year Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| 2026 | $1.55B | +68.83% |
| 2025 | $913.95M | -16.86% |
| 2024 | $1.10B | +92.74% |
| 2023 | $570.38M | +430.51% |
| 2022 | $107.52M | +81.78% |
| 2021 | $59.15M | — |
FAQs About Enliven Therapeutics Inc (ELVN) Market Cap
As of Jan 9, 2026, the market capitalization of ELVN is $1.55B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Enliven Therapeutics Inc’s market capitalization has increased by 33.40%, changing from $1.16B to $1.55B as of Jan 9, 2026.
In the last 3 months, Enliven Therapeutics Inc’s market capitalization has increased by —, changing from – to – as of –.
In the year 2025, Enliven Therapeutics Inc’s market capitalization decreased from $1.10B in January to $913.95M in December, reflecting a -16.86% change.
In the past five years, ELVN has had a compound annual growth rate (CAGR) of 72.90% in market capitalization. This means its market cap has grown at an average rate of 72.90% per year.